Articles with "adverse cardiovascular" as a keyword



Photo by jonathanborba from unsplash

Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery

Sign Up to like & get
recommendations!
Published in 2017 at "JAMA Cardiology"

DOI: 10.1001/jamacardio.2016.4792

Abstract: Importance Major adverse cardiovascular and cerebrovascular events (MACCE) are a significant source of perioperative morbidity and mortality following noncardiac surgery. Objective To evaluate national trends in perioperative cardiovascular outcomes and mortality after major noncardiac surgery… read more here.

Keywords: surgery; adverse cardiovascular; noncardiac surgery; cerebrovascular events ... See more keywords
Photo by tannnpro from unsplash

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.34215

Abstract: Key Points Question What is the risk of major adverse cardiovascular events (MACEs) among patients with a prior intracerebral hemorrhage compared with the general population? Findings In this cohort study, 8991 patients with a prior… read more here.

Keywords: adverse cardiovascular; hemorrhage; major adverse; cardiovascular events ... See more keywords
Photo by nci from unsplash

Patient and lesion‐specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery

Sign Up to like & get
recommendations!
Published in 2017 at "Catheterization and Cardiovascular Interventions"

DOI: 10.1002/ccd.26624

Abstract: To identify predictors of major adverse cardiovascular outcomes (MACE) among patients with prior percutaneous coronary intervention (PCI) who require noncardiac surgery. read more here.

Keywords: among patients; adverse cardiovascular; noncardiac surgery; coronary intervention ... See more keywords
Photo by nci from unsplash

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation

Sign Up to like & get
recommendations!
Published in 2020 at "Clinical Cardiology"

DOI: 10.1002/clc.23344

Abstract: There is a paucity of contemporary data assessing the implications of atrial fibrillation (AF) on major adverse cardiovascular events (MACE) in patients with or at high‐risk for atherosclerotic disease managed in routine practice. read more here.

Keywords: atrial fibrillation; four year; adverse cardiovascular; cardiovascular events ... See more keywords
Photo by sharonmccutcheon from unsplash

Combination of coronary CT angiography, FFRCT, and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD

Sign Up to like & get
recommendations!
Published in 2023 at "Clinical Cardiology"

DOI: 10.1002/clc.23989

Abstract: To examine the utility of fractional flow reserve by coronary computed tomography (CT) angiography (FFRCT) for predicting major adverse cardiovascular events (MACE) in patients with suspected coronary artery disease (CAD). read more here.

Keywords: adverse cardiovascular; patients suspected; angiography ffrct; major adverse ... See more keywords
Photo from wikipedia

Clinical features of potential after-effects of percutaneous coronary intervention in the treatment of silent myocardial ischemia

Sign Up to like & get
recommendations!
Published in 2019 at "Heart and Vessels"

DOI: 10.1007/s00380-019-01444-8

Abstract: Clinical predictors for later adverse cardiovascular events in patients undergoing percutaneous coronary intervention (PCI) for silent myocardial ischemia remain undetermined. We investigated clinical features leading to later adverse cardiovascular events in patients who underwent PCI… read more here.

Keywords: adverse cardiovascular; myocardial ischemia; silent myocardial; cardiovascular events ... See more keywords
Photo from archive.org

The Predictive Value of Lp(a) for Adverse Cardiovascular Event in ACS Patients With an Achieved LDL-C Target at Follow Up After PCI

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Cardiovascular Translational Research"

DOI: 10.1007/s12265-021-10148-2

Abstract: Low-density lipoprotein cholesterol (LDL-C) is a traditional and important risk factor for atherosclerotic cardiovascular disease (CVD). Recently, lipoprotein (a) (lp(a)) attracts considerable attention as a residual risk factor for CVD. However, the roles of lp(a)… read more here.

Keywords: ldl 8mmol; adverse cardiovascular; acs patients; predictive value ... See more keywords
Photo from wikipedia

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

Sign Up to like & get
recommendations!
Published in 2018 at "American Heart Journal"

DOI: 10.1016/j.ahj.2017.10.024

Abstract: Background The objective was to examine the role of a sustained virological response (SVR) on major adverse cardiovascular events (MACEs) in patients with compensated hepatitis C virus (HCV) cirrhosis. Methods Patients with the following criteria… read more here.

Keywords: asian ethnic; adverse cardiovascular; ethnic origin; cardiovascular events ... See more keywords
Photo from wikipedia

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.

Sign Up to like & get
recommendations!
Published in 2019 at "Atherosclerosis"

DOI: 10.1016/j.atherosclerosis.2019.06.896

Abstract: BACKGROUND AND AIMS Elevated lipoprotein(a) [Lp(a)] levels are considered a causal factor for cardiovascular disease. In phase 3 ODYSSEY trials, alirocumab reduced levels of low-density lipoprotein cholesterol (LDL-C) and Lp(a), with concomitant reductions in the… read more here.

Keywords: phase; analysis; mace; adverse cardiovascular ... See more keywords
Photo from wikipedia

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention

Sign Up to like & get
recommendations!
Published in 2020 at "Indian Heart Journal"

DOI: 10.1016/j.ihj.2020.09.002

Abstract: Objective To estimate the incidence of major adverse cardiovascular events (MACE) with genotype test-guided antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome. Methods Patients who had undergone PCI for acute… read more here.

Keywords: intervention; adverse cardiovascular; incidence major; coronary intervention ... See more keywords
Photo from wikipedia

Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score.

Sign Up to like & get
recommendations!
Published in 2017 at "International journal of cardiology"

DOI: 10.1016/j.ijcard.2017.09.154

Abstract: BACKGROUND In addition to thromboembolism, atrial fibrillation (AF) may also predispose to major adverse cardiovascular events (MACE) attributable to coronary artery disease (CAD), including myocardial infarction (MI). The 2MACE score (2 points - Metabolic syndrome… read more here.

Keywords: atrial fibrillation; mace; adverse cardiovascular; 2mace score ... See more keywords